Education
About Us
Working with TipRanks
Follow Us
Brian Tijman Insider Profile
4 Followers
Brian Tijman, Director at Love Pharma Inc, holds 775.66K shares in Uniserve Communications (Ticker: TSE:USS), holds 0.00 shares in Love Pharma Inc (Ticker: TSE:JOLT). Most recently, Brian Tijman Sold ― shares of Uniserve Communications on Dec 11, 2017 for an estimated value of C$50.75K.
Profitable Transactions
7 out of 7 Profitable Transactions
Average Return
+24.40%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Brian Tijman holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Dec 11, 2017 - Dec 11, 2018
Return:+82.50%
The most profitable trade made by Brian Tijman
Brian Tijman's Trading History
Love Pharma Inc
Sep 03, 2009
Director
Uninformative Buy
3.50K
C$0.00
Uniserve Communications
Dec 11, 2017
Senior Officer
Informative Sell
50.75K
C$500.30K
List of latest transactions for each holding click on a transaction to see Brian Tijman's performance on stock
You May Also Like
Brian Tijman insider profile FAQ
What is the percentage of profitable transactions made by Brian Tijman?
The percentage of profitable transactions made by Brian Tijman is 100%.
What is the average return per transaction made by Brian Tijman?
The average return per transaction made by Brian Tijman is 24.40%.
What stocks does Brian Tijman hold?
Brian Tijman holds: TSE:JOLT, TSE:USS stocks.
What was Brian Tijman’s latest transaction?
Brian Tijman latest transaction was an Informative Sell of C$50.75K.
What was Brian Tijman's most profitable transaction?
Brian Tijman’s most profitable transaction was an Informative Sell of TSE:USS stock on December 11, 2017. The return on the trade was 82.50%.
What is Brian Tijman's role in Love Pharma Inc?
Brian Tijman's role in Love Pharma Inc is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.